The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy.
1 other identifier
interventional
30
1 country
1
Brief Summary
Introduction: Gynoid hydrolipodystrophy (HLDG) or cellulitis is a subcutaneous tissue disorder, with several strategies for its treatment, such as caffeine and iontophoresis. Objective: To evaluate the effects of caffeine-associated iontophoresis for the treatment of HLDG. Methods: In a longitudinal study, participants will be evaluated for: photographic documentation, ultrasound imaging, thermography and quality of life questionnaire. If included, they will be separated into 3 randomized groups (n = 30). G1: use of base gel (n = 10); G2: use of iontophoresis and gel with caffeine (n = 10) and G3: use of iontophoresis alone (n = 10). The groups will be treated with 10 sessions, 2 times per week. After that they will be reevaluated. Statistical analysis: The software used will be the SPSS StatisticalPackage (IBM SPSS Statistics, Chicago, IL, USA). The data distribution will be analyzed by the Shapiro-Wilk test. In case of normal distribution, the data will be described as mean ± standard deviation; otherwise, as median \[interquartile range 25-75%\]. For comparison of the data, we will use ANOVA and for comparison of means the Tukey test and case not normal distribution, krulskal-Wallis test and the Dunns test. The level of statistical significance adopted will be P \<0.05. Expected contributions: It is expected that investigators can contribute to the treatment of patients with HLDG and analyze the effects of iontophoresis with caffeine, both in clinical and scientific practice, providing a method that is valid and reliable for this purpose; multidisciplinary training of highly qualified human resources and the strengthening and consolidation of a research team.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jun 2018
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2018
CompletedFirst Posted
Study publicly available on registry
June 14, 2018
CompletedStudy Start
First participant enrolled
June 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 17, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 4, 2019
CompletedApril 16, 2019
April 1, 2019
9 months
May 15, 2018
April 15, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
thickness
change from baseline subcutaneous adipose tissue thickness at after 10 sessions
through study completion, an average of 1 year.
Secondary Outcomes (2)
temperature
through study completion, an average of 1 year.
score quality of life
through study completion, an average of 1 year.
Study Arms (3)
group 1
ACTIVE COMPARATORtopical gel base + caffeine.
group 2
ACTIVE COMPARATORiontophoresis + caffeine
Group 3
ACTIVE COMPARATORiontophoresis
Interventions
we will use cafeislaine c (caffeine) +galvanic current
Eligibility Criteria
You may qualify if:
- Patients with mild to moderate cellulite diagnosis will be included, according to the validated Photonumeric scale of cellulite severity
- Body mass index less than 30 (kg / m2)
You may not qualify if:
- Individuals who have a deregulated menstrual cycle who are pregnant;
- Breastfeeding or using some hormone;
- Antibiotic medication including steroids over 1 month of treatment of skin diseases; •Sensitivity or hypersensitivity of the skin;
- Use of the same or similar cosmetics or remedies on the glutes within 1 month;
- Surgical procedure (liposuction and skin treatments) in the region to be treated or planning some procedure within the study period;
- Chronic debilitating diseases such as asthma, diabetes or hypertension;
- Atopic dermatitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rodrigo Antonio Carvalho Andraus
Londrina, Paraná, 86.041-140, Brazil
Related Publications (2)
Hexsel DM, Dal'forno T, Hexsel CL. A validated photonumeric cellulite severity scale. J Eur Acad Dermatol Venereol. 2009 May;23(5):523-8. doi: 10.1111/j.1468-3083.2009.03101.x. Epub 2009 Feb 13.
PMID: 19220646RESULTYoo MA, Seo YK, Ryu JH, Back JH, Koh JS. A validation study to find highly correlated parameters with visual assessment for clinical evaluation of cosmetic anti-cellulite products. Skin Res Technol. 2014 May;20(2):200-7. doi: 10.1111/srt.12106. Epub 2013 Sep 7.
PMID: 24010809RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rodrigo A Andraus
Universidade Norte do Paraná
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master student
Study Record Dates
First Submitted
May 15, 2018
First Posted
June 14, 2018
Study Start
June 14, 2018
Primary Completion
March 17, 2019
Study Completion
April 4, 2019
Last Updated
April 16, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share